100 related articles for article (PubMed ID: 6259303)
1. Imaging of experimental myocardial infarction with technetium-99m 2,3-dimercaptosuccinic acid.
Karlsberg RP; Milne N; Lyons KP; Aronow WS
J Nucl Med; 1981 Mar; 22(3):253-7. PubMed ID: 6259303
[TBL] [Abstract][Full Text] [Related]
2. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic detection of experimental myocardial infarction with 99mTc-2,3-dimercaptosuccinic acid.
Duska F; Novák J; Mazurová Y; Kubícek J; Vizd'a J; Kafka P; Veverková O
Nuklearmedizin; 1984 Dec; 23(6):317-9. PubMed ID: 6099542
[TBL] [Abstract][Full Text] [Related]
4. [Scintigraphic detection of acute experimental myocardial infarct in dogs using 99m-2,3-dimercaptosuccinate].
Duska F; Kubícek J; Novák J; Kafka P; Vizda J; Mazurová Y
Cas Lek Cesk; 1984 Dec; 123(52):1590-4. PubMed ID: 6097358
[No Abstract] [Full Text] [Related]
5. Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): in vitro correlation.
Daly MJ; Jones W; Rudd TG; Tremann J
J Nucl Med; 1979 Jan; 20(1):63-6. PubMed ID: 219166
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.
Yee CA; Lee HB; Blaufox MD
J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
8. Regional 99m technetium diphosphonate uptake in experimental dog heart infarct: relation to duration and severity of ischaemia.
Peter T; Norris RM; Heng MK; Sammel NL
Cardiovasc Res; 1979 Nov; 13(11):635-41. PubMed ID: 519666
[TBL] [Abstract][Full Text] [Related]
9. Effect of coronary blood flow and site of injection on Tc-99m PPi detection of early canine myocardial infarcts.
Parkey RW; Kulkarni PV; Lewis SE; Datz FL; Dehmer GJ; Gutekunst DP; Buja LM; Bonte FJ; Willerson JT
J Nucl Med; 1981 Feb; 22(2):133-7. PubMed ID: 7463157
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
11. Optimal handling of dimercaptosuccinic acid for quantitative renal scanning.
Taylor A; Lallone RL; Hagan PL
J Nucl Med; 1980 Dec; 21(12):1190-3. PubMed ID: 6255114
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons.
Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF
J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398
[TBL] [Abstract][Full Text] [Related]
13. Renal handling of technetium-99m DMSA: further evidence for glomerular filtration and proximal tubular reabsorption.
van Luijk WH; Piers DA; Beekhuis H; Meijer S
J Nucl Med; 1986 Dec; 27(12):1943. PubMed ID: 3023565
[No Abstract] [Full Text] [Related]
14. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA).
Westera G; Gadze A; Horst W
Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143
[TBL] [Abstract][Full Text] [Related]
15. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
[TBL] [Abstract][Full Text] [Related]
16. [The pathophysiologic basis for the incorporation of 99mTc-pyrophosphate into myocardial infarct].
Duska F; Hadas L; Volenec K; Palicka V; Mazurová Y; Vizd'a J; Kafka P; Urbanová E; Kuba M; Veverková O
Cesk Radiol; 1989 Aug; 43(4):241-9. PubMed ID: 2551518
[TBL] [Abstract][Full Text] [Related]
17. [99mTechnetium dimercaptosuccinic acid (DMSA): animal experimental studies and clinical results].
Krüger M; Unterspann S; Finck W
Radiobiol Radiother (Berl); 1979 Jun; 20(3):407-11. PubMed ID: 229509
[No Abstract] [Full Text] [Related]
18. 2,3-Dimercaptosuccinic-acid chelates--1. Structure and pharmacokinetic studies.
Moretti JL; Rapin JR; Saccavini JC; Lageron A; Le Poncin M; Bardy A
Int J Nucl Med Biol; 1984; 11(3-4):270-4. PubMed ID: 6099340
[No Abstract] [Full Text] [Related]
19. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid.
Orlandi C; Crane PD; Edwards DS; Platts SH; Bernard L; Lazewatsky J; Thoolen MJ
J Nucl Med; 1991 Feb; 32(2):263-8. PubMed ID: 1992031
[TBL] [Abstract][Full Text] [Related]
20. Basal kinetic studies of Tc-99m DMPE as a myocardial imaging agent in the dog.
Nishiyama H; Deutsch E; Adolph RJ; Sodd VJ; Libson K; Saenger EL; Gerson MC; Gabel M; Lukes SJ; Vanderheyden JL; Fortman DL; Scholz KL; Grossman LW; Williams CC
J Nucl Med; 1982 Dec; 23(12):1093-101. PubMed ID: 7150424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
